newsThe company’s second quarter (Q2) results reveal a $9.1 billion…
2 August 2021 | By Hannah Balfour (European Pharmaceutical Review)
The company’s second quarter (Q2) results reveal a $9.1 billion increase in revenues from Q2 2020 and significant operational growth.